Helene A. Emsellem

Sleep Medicine

901 23rd St NW
Washington, DC 20037

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Fatigue is distinct from sleepiness and negatively impacts individuals living with obstructive sleep apnea (OSA): results from qualitative research of individuals with OSA.

Fatigue is distinct from sleepiness and negatively impacts individuals living with obstructive sleep apnea (OSA): results from qualitative research of individuals with OSA.

Journal: Health and quality of life outcomes

Published: August 31, 2024

Corrigendum: Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study.

Corrigendum: Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study.

Journal: Frontiers in neuroscience

Published: November 27, 2023

Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study.

Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study.

Journal: Frontiers in neuroscience

Published: September 01, 2023

Safety and pharmacodynamics of a single infusion of danavorexton in adults with idiopathic hypersomnia.

Safety and pharmacodynamics of a single infusion of danavorexton in adults with idiopathic hypersomnia.

Journal: Sleep

Published: November 30, 2022

Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility.

Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility.

Journal: Sleep & breathing = Schlaf & Atmung

Published: February 02, 2022

Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial.

Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: October 02, 2020

Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial.

Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial.

Journal: CNS drugs

Published: June 27, 2020

Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy.

Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy.

Journal: Sleep medicine

Published: September 23, 2019

The reimagining of sleep and health.

The reimagining of sleep and health.

Journal: Sleep health

Published: January 24, 2019

NightBalance Sleep Position Treatment Device Versus Auto-Adjusting Positive Airway Pressure for Treatment of Positional Obstructive Sleep Apnea.

NightBalance Sleep Position Treatment Device Versus Auto-Adjusting Positive Airway Pressure for Treatment of Positional Obstructive Sleep Apnea.

Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

Published: January 12, 2019

Explore sleep health under one roof.

Explore sleep health under one roof.

Journal: Sleep health

Published: November 17, 2018

A randomized study of solriamfetol for excessive sleepiness in narcolepsy.

A randomized study of solriamfetol for excessive sleepiness in narcolepsy.

Journal: Annals of neurology

Published: July 27, 2018

Showing 1-12 of 21

Last Updated: 09/26/2026